Andrographolide modulates OPG/RANKL axis to promote osteoblastic differentiation in MC3T3-E1 cells and protects bone loss during estrogen deficiency in rats

Publication date: November 2020Source: Biomedicine & Pharmacotherapy, Volume 131Author(s): Duangrat Tantikanlayaporn, Patsorn Wichit, Kanoknetr Suksen, Apichart Suksamrarn, Pawinee Piyachaturawat
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research